Projects funded by the NCN
The evaluation of therapeutic potential of β-caryophyllene in animal schizophrenia model - behavioral and molecular studies.
2022/45/N/NZ7/04059
Keywords:
schizophrenia cannabinoids endocannabinoid system CB2 receptor β-caryophyllene NMDA receptor antagonism
Descriptors:
- NZ7_014:
- NZ7_012:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii PAN
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 21 - announced on 2022-03-28
Amount awarded: 138 803 PLN
Project start date (Y-m-d): 2023-02-17
Project end date (Y-m-d): 2026-02-16
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publications will be made available after the final report has been accepted.